1. United States Stocks

  2. •

    Technology services

  3. •

    Packaged software
RXO, Inc.

RXO, Inc.

28.92
USD
+0.14
(+0.49%)
-0.62EPS
4.55BMarket Cap
Nov 05Next Earn
RXO, Inc.
NYSE:RXO
(New York Stock Exchange)

Recent

price

28.92

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
TTM
USD
27.29
29.16
40.73
41.58
33.6
34.1
34.08
36.03
Revenue per Share
0.54
0.37
1.3
0.8
0.03
-2.17
-0.59
-0.62
Basic EPS, GAAP
0.58
-0.19
1.01
2.19
0.21
-0.43
-0.05
-0.45
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
9.28
9.3
5.04
5.08
9.92
9.39
9.13
Book Value per Share
- -
2.73
2.95
-1.05
-0.89
-0.06
-0.14
-0.22
Tangible Book Value per Share
115
115
115
115
117
133
168
169
Basic Weighted Avg Shares
3,141
3,357
4,689
4,796
3,927
4,550
5,742
6,089
Sales/Revenue/Turnover
2.93
2.5
4.18
4.59
1.71
0.66
-0.12
-0.23
Operating Margin (%)
74
76
81
86
67
87
116
106
Depreciation Expense
62
43
150
92
4
-290
-100
-105
Net Income, GAAP
26.19
24.56
21.47
22.69
- -
- -
- -
- -
Effective Tax Rate (%)
1.97
1.28
3.2
1.92
0.1
-6.37
-1.74
-1.72
Profit Margin (%)
- -
233
267
206
114
274
279
329
Working Capital
- -
86
93
565
502
566
578
626
LT Debt
- -
1,068
1,070
587
594
1,612
1,541
1,506
Total Equity
- -
- -
12.72
7.97
3.35
- -
- -
- -
Return on Invested Capital (%)
- -
- -
12.56
7.89
3.06
- -
- -
- -
Return on Capital (%)
- -
- -
14.03
11.1
0.68
-26.29
-6.34
-6.79
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
92
87
102
LT Borrowings
387
430
459
LT Finance Leases
191
182
167
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
164
165
165
Market Capitalization
2,075
2,410
4,550

Working Capital

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,317
1,335
1,556
Cash, Cash Equivalents & STI
17
21
15
Accounts Receivable, Net
1,226
1,216
1,444
Inventories
- -
- -
- -
Total Current Liabilities
1,038
1,048
1,227
Payables & Accruals
936
951
1,117
ST Debt
92
87
102
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
24.64%
-4.4%
Free Cash Flow
- -
-202.65%
-85.96%
Net Income, GAAP
- -
-1,460.2%
-65.52%
Sales/Revenue/Turnover
- -
13.18%
26.2%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
913
930
1,040
1,667
4,550
2025
1,433
1,419
1,421
1,469
5,742
2026
1,425
1,774
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.13
-0.06
-1.81
-0.15
-2.17
2025
-0.18
-0.05
-0.08
-0.27
-0.59
2026
-0.21
-0.05
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Microsoft Corporation (NASDAQ:MSFT)
Palantir Technologies Inc. (NASDAQ:PLTR)
Nebius Group N.V. (NASDAQ:NBIS)
Oracle Corporation (NYSE:ORCL)
CoreWeave, Inc. (NASDAQ:CRWV)
ServiceNow, Inc. (NYSE:NOW)
Business
RXO delivers asset-light transportation solutions primarily across North America. The company leverages its advanced, proprietary digital freight marketplace to connect shippers with a vast network of carriers, optimizing access to diverse truckload capacity. Beyond brokered freight, they provide integrated services including managed transportation, specialized last-mile delivery, and global freight forwarding. The firm maintains its corporate headquarters in Charlotte, North Carolina.

Company News

Company News APIChatGPT

  • gurufocus.com

    Are BRZE, SLN, OPCH, RXO Obtaining Fair Deals for their Shareholders?

  • globenewswire.com

    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silence Therapeutics plc (Nasdaq – SLN), Option Care Health, Inc. (Nasdaq – OPCH), RXO Inc. (NYSE – RXO), Sangoma Technologies Corporation (Nasdaq – SANG)

  • gurufocus.com

    Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?

  • prnewswire.com

    Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?

  • marketbeat.com

    C.H. Robinson Bets Its AI Story on RXO—But the Market Isn't Sold

  • fool.com

    Breakfast News: Week in Review

  • prnewswire.com

    $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of RXO, Inc. (NYSE: RXO)

  • zacks.com

    C.H. Robinson to Benefit From RXO Acquisition: Here's How

  • gurufocus.com

    RXO Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RXO Inc. - RXO

  • businesswire.com

    RXO Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RXO Inc. - RXO

  • zacks.com

    RXO (RXO) Is Attractively Priced Despite Fast-paced Momentum

  • benzinga.com

    Top 3 Industrials Stocks You May Want To Dump In October

  • defenseworld.net

    RXO (NYSE:RXO) Stock Rating Cut to “Hold” at Jefferies Financial Group

  • 247wallst.com

    Here Are Tuesday’s Top Wall Street Analyst Research Calls: Borg Warner, Boyd Gaming, JetBlue, Lattice Semiconductor, Lockheed Martin, Nike, Northrop Grumman, Procter & Gamble, SPX Technologies, and More

  • wsj.com

    Freight Broker C.H. Robinson to Buy Smaller Rival RXO

  • gurufocus.com

    Are RXO, PTC, LFCR, WAFD Obtaining Fair Deals for their Shareholders?

  • globenewswire.com

    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR), WaFd, Inc. (Nasdaq – WAFD)

  • fool.com

    Why C.H Robinson Stock Was Tumbling Today

  • businesswire.com

    RXO Stock Alert: Halper Sadeh LLC is Investigating Whether RXO Inc. is Obtaining a Fair Price for its Shareholders

  • zacks.com

    RXO (RXO) Upgraded to Buy: What Does It Mean for the Stock?